It’s no secret that medical marijuana has been making a comeback over the past couple of years. And now, magic mushrooms or psilocybin may be headed down the same path for some patients.

According to CBS News New York, “In a trial at New York University, doctors gave Marritz and 31 other cancer patients psilocybin, the active ingredient in psychedelic mushrooms, to see if it could ease their depression after one-time use …

“…Guss, one of the study’s directors, said the outcomes were stunning; like Marritz, two thirds of patients had positive and long-lasting results.”